Pharmafile Logo
Pharmafocus logo
Advanced Search

Diseases

Showing 1 posts of 1 posts found.

Immupharma and Avion sign agreement for lupus drug Lupuzor

November 29, 2019
Medical Communications Diseases, Lupus, Lupuzor, avion

Immupharma has signed a development agreement with Avion Pharmaceuticals to acquire the licensing rights for Lupuzor, a peptide therapeutic and …

News
The Gateway to Local Adoption Series

Latest content

Long-acting therapies set to reshape HIV treatment market

August 21, 2026

MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy

August 21, 2026

MHRA approves Romvimza for tenosynovial giant cell tumour

August 20, 2026

NICE recommends allergy immunotherapy tablets for younger children

August 19, 2026

Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement

August 18, 2026